Tirzepatide — 10mg

Tirzepatide is a dual GLP-1/GIP receptor agonist peptide representing a significant advancement in metabolic research. By targeting two incretin receptors simultaneously, it demonstrates superior effects on glucose regulation and body weight reduction compared to single-receptor agonists.

Mechanism of Action

• GLP-1 agonist: Enhances insulin secretion and reduces appetite
• GIP agonist: Improves insulin sensitivity and modulates fat storage
• Dual synergy: Combined receptor activation produces additive metabolic benefits

Research Areas

• Type 2 diabetes management
• Obesity and adipose tissue reduction
• Metabolic syndrome
• Cardiovascular outcomes

⚠️ Research Use Only (RUO) Notice

All products available on PeptidesLab.tech are strictly intended for laboratory research purposes only. They are not intended for human or animal consumption, and must not be used for medical, therapeutic, or diagnostic applications under any circumstances.

By purchasing from this website, you acknowledge and agree that you are a qualified professional or researcher, and that you fully understand the nature and risks associated with handling research-use-only substances.

PeptidesLab.tech reserves the right to request proof of professional or research status prior to processing or shipping any order. Failure to provide adequate documentation upon request may result in order cancellation at our sole discretion.